Literature DB >> 27467572

Mumps Outbreak at a University and Recommendation for a Third Dose of Measles-Mumps-Rubella Vaccine - Illinois, 2015-2016.

Justin P Albertson, Whitney J Clegg, Heather D Reid, Benjamin S Arbise, Julie Pryde, Awais Vaid, Rachella Thompson-Brown, Fredrick Echols.   

Abstract

Mumps is an acute viral disease characterized by fever and swelling of the parotid or other salivary glands. On May 1, 2015, the Illinois Department of Public Health (IDPH) confirmed a mumps outbreak at the University of Illinois at Urbana-Champaign. IDPH and the Champaign-Urbana Public Health District (C-UPHD) conducted an investigation and identified 317 cases of mumps during April 2015-May 2016. Because of sustained transmission in a population with high 2-dose coverage with measles-mumps-rubella (MMR) vaccine, a third MMR dose was recommended by IDPH, C-UPHD, and the university's McKinley Health Center. No formal recommendation for or against the use of a third MMR dose has been issued by the Advisory Committee on Immunization Practices (ACIP) (1). However, CDC has provided guidelines for use of a third dose as a control measure during mumps outbreaks in settings in which persons are in close contact with one another, where transmission is sustained despite high 2-dose MMR coverage, and when traditional control measures fail to slow transmission (2).

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27467572     DOI: 10.15585/mmwr.mm6529a2

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  22 in total

1.  Mumps in a 27-year-old man.

Authors:  J Brad Wiggers; Tiffany Chan; Wayne L Gold; Derek R MacFadden
Journal:  CMAJ       Date:  2017-04-18       Impact factor: 8.262

2.  Immunogenicity of mumps virus vaccine candidates matching circulating genotypes in the United States and China.

Authors:  James Zengel; Shannon I Phan; Adrian Pickar; Pei Xu; Biao He
Journal:  Vaccine       Date:  2017-06-13       Impact factor: 3.641

Review 3.  Mumps: an Update on Outbreaks, Vaccine Efficacy, and Genomic Diversity.

Authors:  Eugene Lam; Jennifer B Rosen; Jane R Zucker
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

4.  Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak Control.

Authors:  Cristina V Cardemil; Rebecca M Dahl; Lisa James; Kathleen Wannemuehler; Howard E Gary; Minesh Shah; Mona Marin; Jacob Riley; Daniel R Feikin; Manisha Patel; Patricia Quinlisk
Journal:  N Engl J Med       Date:  2017-09-07       Impact factor: 91.245

5.  Diagnostic Yield of Laboratory Methods and Value of Viral Genotyping during an Outbreak of Mumps in a Partially Vaccinated Population in British Columbia, Canada.

Authors:  Alexandra Nunn; Shazia Masud; Mel Krajden; Monika Naus; Agatha N Jassem
Journal:  J Clin Microbiol       Date:  2018-04-25       Impact factor: 5.948

6.  Differential durability of immune responses to measles and mumps following MMR vaccination.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Antonia Thomas; Beth R Larrabee; Steven Rubin; Gregory A Poland
Journal:  Vaccine       Date:  2019-02-20       Impact factor: 3.641

7.  Vaccine waning and mumps re-emergence in the United States.

Authors:  Joseph A Lewnard; Yonatan H Grad
Journal:  Sci Transl Med       Date:  2018-03-21       Impact factor: 17.956

8.  Mumps Outbreak in a Highly Vaccinated University-Affiliated Setting Before and After a Measles-Mumps-Rubella Vaccination Campaign-Iowa, July 2015-May 2016.

Authors:  Minesh Shah; Patricia Quinlisk; Andrew Weigel; Jacob Riley; Lisa James; James Patterson; Carole Hickman; Paul A Rota; Rebekah Stewart; Nakia Clemmons; Nicholas Kalas; Cristina Cardemil
Journal:  Clin Infect Dis       Date:  2018-01-06       Impact factor: 9.079

9.  Investigation and management of a large community mumps outbreak among young adults in Toronto, Canada, January 2017-February 2018.

Authors:  V Dubey; O Ozaldin; L Shulman; R Stuart; J Maclachlan; L Bromley; A Summers
Journal:  Can Commun Dis Rep       Date:  2018-12-06

10.  Cost of Public Health Response and Outbreak Control With a Third Dose of Measles-Mumps-Rubella Vaccine During a University Mumps Outbreak-Iowa, 2015-2016.

Authors:  Mona Marin; Tricia L Kitzmann; Lisa James; Patricia Quinlisk; Wade K Aldous; John Zhang; Cristina V Cardemil; Chris Galeazzi; Manisha Patel; Ismael R Ortega-Sanchez
Journal:  Open Forum Infect Dis       Date:  2018-10-04       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.